ASCO 2024 Highlights Part 1 - Plenary

Episode
221
Soundcloud
Share

ASCO 2024 presented so much lung cancer data that two podcast episodes are required to cover all the data. In this first episode, hosts Dr. Stephen Liu and Dr. Narjust Florez cover the LAURA trial, the ADUARA trial, the KRYSTAL-12 study, the phase III EVOKE-01 trial, the phase III ADRIATIC trial, and the REACH-PC trial.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Lecia Sequist
Lecia Sequist

MD

Program Director for Cancer Early Detection & Diagnostics
Massachusetts General Cancer Center
Landry Family Professor of Medicine in the Field of Medical Oncology at Harvard Medical School
David Spigel
David Spigel

MD

Chief Scientific Officer
Sarah Cannon Research Institute
IASLC Heine H. Hansen Lectureship for SCLC Recipient